1. Diagnostic accuracy of cystatin C compared to serum creatinine for the estimation of renal dysfunction in adults and children—a meta-analysis;Roos;Clin. Biochem.,2007
2. A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with b-thalassemia;Cappellini;Blood,2006
3. Phase II clinical evaluation of deferasirox, a once-daily oral chelating agent, in pediatric patients with β-thalassemia major;Galanello;Haematologica,2006
4. Randomized phase II trial of deferasirox (Exjade®, ICL670), a once-daily, orally-administered iron chelator, in comparison to deferoxamine in thalassemia patients with transfusional iron overload;Piga;Haematologica,2006
5. Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective study;Porter;Eur. J. Haematol.,2008